Thema: JP3207000005
Kaken, JP3207000005
money-5338733_1920.jpg - Foto: THN
Kaken stock: ND081 collaboration highlights IBD pipeline option
Kaken stock is in focus after a reported collaboration with Numab on the inflammatory bowel disease candidate ND081. The deal expands Kaken's external innovation pipeline.
ad-hoc-news.de, heute 01:11 Uhr
Kaken, JP3207000005
Kaken stock: Kaken posts October 22 notice. Kaken stock ...
Kaken stock has a JPY 4,575 consensus target from four ratings. First-quarter revenue reached JPY 30.15 billion on August 7, 2026.
ad-hoc-news.de, 23.10.26 04:44 Uhr
Kaken, JP3207000005
Kaken updates 2026 ESG data: Kaken Pharmaceutical stock ...
Kaken updated ESG data on September 30, 2026. Kaken Pharmaceutical stock posted JPY 30.15 billion in first-quarter revenue.
ad-hoc-news.de, 20.10.26 01:49 Uhr
Kaken, JP3207000005
Kaken reports JPY 30.15 billion revenue: Kaken Pharmaceutical ...
Kaken Pharmaceutical stock posted JPY 8.44 billion net income in the first quarter. Full-year sales guidance is JPY 89.90 billion.
ad-hoc-news.de, 14.10.26 02:47 Uhr
